ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
In treatment naïve HIV infected subjects, combination antiretroviral therapy including
efavirenz combined with tenofovir and emtricitabine will offer non-inferior antiretroviral
efficacy over 48 weeks, compared to either atazanavir boosted with ritonavir combined with
tenofovir and emtricitabine or tenofovir and emtricitabine combined with zidovudine and
abacavir, as assessed by change from baseline plasma HIV-1 RNA viral load.